why is ibrx stock dropping:IBRX News Today

IBRX News Today

IBRX News Today

AsofJune30th,therewasshortinteresttotalling49,080,000shares,adropof8.2%fromtheJune15thtotalof53,440,000shares.。其他文章還包含有:「WhyImmunitybioInc's(IBRX)StockIsDown14.64%」、「ImmunityBio」、「ImmunityBio(IBRX)ReportsQ2Loss」、「WhyImmunitybioInc's(IBRX)StockIsDown6.11%」、「Recent14%DeclineMayNotHaveGoneDownWellWith...」、「BillionaireLATimesOwnerSitsOn$10BillionNightmare...」、「...

查看更多 離開網站

Provide From Google
Why Immunitybio Inc's (IBRX) Stock Is Down 14.64%
Why Immunitybio Inc's (IBRX) Stock Is Down 14.64%

https://www.aaii.com

As of Monday, May 06, Immunitybio Inc's IBRX share price has dipped by 14.64%, which has investors questioning if this is right time to buy.

Provide From Google
ImmunityBio
ImmunityBio

https://finance.yahoo.com

Chief Scientific Officer Patrick Soon-Shiong, ImmunityBio, Inc.'s (NASDAQ:IBRX) largest shareholder sees value of holdings go down 6.5% after recent drop.

Provide From Google
ImmunityBio (IBRX) Reports Q2 Loss
ImmunityBio (IBRX) Reports Q2 Loss

https://finance.yahoo.com

ImmunityBio (IBRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.17.

Provide From Google
Why Immunitybio Inc's (IBRX) Stock Is Down 6.11%
Why Immunitybio Inc's (IBRX) Stock Is Down 6.11%

https://www.aaii.com

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can ...

Provide From Google
Recent 14% Decline May Not Have Gone Down Well With ...
Recent 14% Decline May Not Have Gone Down Well With ...

https://www.moomoo.com

(NASDAQ:IBRX), then you'll have to look at the makeup of its share registry. With 66% stake, individual insiders possess the maximum shares in the company.

Provide From Google
Billionaire LA Times Owner Sits On $10 Billion Nightmare ...
Billionaire LA Times Owner Sits On $10 Billion Nightmare ...

https://www.investors.com

The value of the biotechnology company crashed 91% since trading started on March 10, 2021. The S&P 500 is up 24% in that time.

Provide From Google
ImmunityBio
ImmunityBio

https://seekingalpha.com

Given this cash burn rate, IBRX has somewhere in the realm of 1 to 2 quarters of cash runway on hand to continue funding operations. This does ...

Provide From Google
ImmunityBio stock loses more than half its value after ...
ImmunityBio stock loses more than half its value after ...

https://www.marketwatch.com

ImmunityBio stock loses more than half its value after disclosing FDA can't approve the BLA for its cancer treatment in its present form. By.

Provide From Google
Immunitybio Inc (IBRX) Latest News & Price
Immunitybio Inc (IBRX) Latest News & Price

https://investorplace.com

ImmunityBio (IBRX) stock is falling on Thursday after the company got a response letter from the FDA concerning its bladder cancer treatment.